Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Income Before Tax

-$37.39M

TTM · Period ending: · USD

LCTX logo

LCTX Income Before Tax

Latest reported-$37.39M
LCTX TTM Pre-Tax Income ($0.00 → -$37.39M)
High-resolution chart · PNG

LCTX income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
-37,385,000
-69,293,000
-68,647,000
-67,509,000
-40,758,000
-16,167,000
-18,582,000
-20,046,000
-24,203,000
-23,633,000
-23,282,000
-24,930,000
-23,347,000
-24,926,000
-25,812,000
-47,459,000
-50,730,000
-48,913,000
-43,268,000
-14,275,000
-13,379,000
-14,944,000
-21,924,000
-28,248,000
-37,804,000
-62,574,000
-19,234,000
-59,224,000
24,826,000
51,480,000
-47,130,000
-78,644,000
-126,430,000
-137,888,000
-23,289,000
45,814,000
56,321,000
93,650,000
18,752,000
8,567,000
-38,387,000
-72,879,000
-62,648,937
-59,699,189
-54,274,339
-53,914,305
-51,224,425
-65,583,892
-63,576,060
-58,864,707
-56,196,195
-34,012,418
-29,685,343
-27,487,347
-25,321,437
-23,634,608
-21,944,895
-20,903,826
-18,522,882
-16,656,448
-14,874,622
-12,271,761
-9,696,834
-4,350,337
-4,813,724
-3,565,868
-3,189,291
-8,718,004
-6,874,107
-6,431,056
-5,996,917
-3,654,248
-2,790,545
-2,471,842
-2,549,656
-2,976,051
-3,102,595
-2,758,518
-2,682,843
-1,229,114
-1,304,137
-1,304,137
-1,552,540
-1,739,220
-1,726,704
-2,168,972
-3,085,324
-2,853,237
-2,088,675
-2,398,759
-1,426,946
-3,338,561
-3,700,581
-3,516,061
-2,844,932
-567,832
-567,832
0
0
4,049,944
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.